![](/img/cover-not-exists.png)
ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer
Zhang, Yue, Bi, Jiajia, Zhu, Hongtao, Shi, Mei, Zeng, XianluLanguage:
english
Journal:
Bioscience, Biotechnology, and Biochemistry
DOI:
10.1080/09168451.2018.1484275
Date:
June, 2018
File:
PDF, 1.76 MB
english, 2018